Search Results

There are 247960 results for: content related to: Modeling complex decay profiles of hepatitis B virus during antiviral therapy

  1. You have free access to this content
    Viral dynamics of hepatitis B virus DNA in human immunodeficiency virus-1–hepatitis B virus coinfected individuals: Similar effectiveness of lamivudine, tenofovir, or combination therapy


    Volume 49, Issue 4, April 2009, Pages: 1113–1121, Sharon R. Lewin, Ruy M. Ribeiro, Anchalee Avihingsanon, Scott Bowden, Gail Matthews, Pip Marks, Stephen A. Locarnini, Kiat Ruxrungtham, Alan S. Perelson and Gregory J. Dore

    Version of Record online : 25 NOV 2008, DOI: 10.1002/hep.22754

  2. You have free access to this content
    Analysis of hepatitis B viral load decline under potent therapy: Complex decay profiles observed


    Volume 34, Issue 5, November 2001, Pages: 1012–1020, Sharon R. Lewin, Ruy M. Ribeiro, Tomos Walters, George K. Lau, Scott Bowden, Stephen Locarnini and Alan S. Perelson

    Version of Record online : 30 DEC 2003, DOI: 10.1053/jhep.2001.28509

  3. You have free access to this content
    AASLD Abstracts


    Volume 56, Issue S1, October 2012, Pages: 191A–1144A,

    Version of Record online : 1 OCT 2012, DOI: 10.1002/hep.26040

  4. HBV DNA suppression in HBeAg-positive chronic hepatitis B patients treated with peginterferon or placebo

    Journal of Medical Virology

    Volume 83, Issue 11, November 2011, Pages: 1917–1923, Bettina E. Hansen, Vincent Rijckborst, Martijn J. ter Borg and Prof. Harry L.A. Janssen

    Version of Record online : 13 SEP 2011, DOI: 10.1002/jmv.22208

  5. You have free access to this content
    JSH Guidelines for the Management of Hepatitis B Virus Infection

    Hepatology Research

    Volume 44, Issue S1, January 2014, Pages: 1–58, Drafting Committee for Hepatitis Management Guidelines and the Japan Society of Hepatology

    Version of Record online : 7 JAN 2014, DOI: 10.1111/hepr.12269

  6. Role of monokine induced by interferon-γ in liver injury induced by hepatitis B virus in mice

    Journal of Viral Hepatitis

    Volume 19, Issue 7, July 2012, Pages: 509–518, Y. J. Xia, D. Zeng, L. M. Xia, F. Yu, H. H. Lin, L. Zhou, D. A. Tian and M. Liu

    Version of Record online : 28 JAN 2012, DOI: 10.1111/j.1365-2893.2011.01581.x

  7. Effect of Peg-interferon α-2a combined with Adefovir in HBV postpartum women with normal levels of ALT and high levels of HBV DNA

    Liver International

    Volume 35, Issue 6, June 2015, Pages: 1692–1699, Junfeng Lu, Shibin Zhang, Yali Liu, Xiaofei Du, Shan Ren, Hua Zhang, Lina Ma, Yue Chen, Xinyue Chen and Chengli Shen

    Version of Record online : 21 JAN 2015, DOI: 10.1111/liv.12753

  8. You have free access to this content
    Modulation of hepatitis B virus replication and hepatocyte differentiation by MicroRNA-1


    Volume 53, Issue 5, May 2011, Pages: 1476–1485, Xiaoyong Zhang, Ejuan Zhang, Zhiyong Ma, Rongjuan Pei, Min Jiang, Joerg F. Schlaak, Michael Roggendorf and Mengji Lu

    Version of Record online : 22 APR 2011, DOI: 10.1002/hep.24195

  9. HIV/HCV and HIV/HBV Co-infections

    Mount Sinai Expert Guides: Hepatology

    Marie-Louise C. Vachon, Alicia C. Stivala, Douglas T. Dieterich, Pages: 78–95, 2014

    Published Online : 14 FEB 2014, DOI: 10.1002/9781118748626.ch7

  10. You have free access to this content
    AASLD Abstracts 895–1142


    Volume 48, Issue S1, October 2008, Pages: 707A–816A,

    Version of Record online : 24 SEP 2008, DOI: 10.1002/hep.22644

  11. You have free access to this content
    Poster Session 4: Stem Cell Biology; Varices and Bleeding


    Volume 62, Issue S1, October 2015, Pages: 1195A–1215A,

    Version of Record online : 7 OCT 2015, DOI: 10.1002/hep.28243

  12. 4′-modified nucleoside analogs: Potent inhibitors active against entecavir-resistant hepatitis B virus


    Volume 62, Issue 4, October 2015, Pages: 1024–1036, Yuki Takamatsu, Yasuhito Tanaka, Satoru Kohgo, Shuko Murakami, Kamalendra Singh, Debananda Das, David J. Venzon, Masayuki Amano, Nobuyo Higashi-Kuwata, Manabu Aoki, Nicole S. Delino, Sanae Hayashi, Satoru Takahashi, Yoshikazu Sukenaga, Kazuhiro Haraguchi, Stefan G. Sarafianos, Kenji Maeda and Hiroaki Mitsuya

    Version of Record online : 25 AUG 2015, DOI: 10.1002/hep.27962

  13. You have free access to this content
    Early serum HBsAg level as a strong predictor of sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B

    Alimentary Pharmacology & Therapeutics

    Volume 35, Issue 4, February 2012, Pages: 458–468, C.-Y. Peng, H.-C. Lai, Y.-F. Li, W.-P. Su, P.-H. Chuang and J.-T. Kao

    Version of Record online : 8 JAN 2012, DOI: 10.1111/j.1365-2036.2011.04973.x

  14. Tenofovir for the Treatment of Hepatitis B Virus

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 29, Issue 10, October 2009, Pages: 1212–1227, Dr. Alice M. Jenh, Dr. Chloe L. Thio and Dr. Paul A. Pham

    Version of Record online : 6 JAN 2012, DOI: 10.1592/phco.29.10.1212

  15. You have free access to this content
    HBV Virology and Diagnostics


    Volume 58, Issue S1, October 2013, Pages: 705A–730A,

    Version of Record online : 15 OCT 2013, DOI: 10.1002/hep.26857

  16. HBsAg plasma level kinetics: a new role for an old marker as a therapy response predictor in vertically infected children on combination therapy

    Journal of Viral Hepatitis

    Volume 22, Issue 4, April 2015, Pages: 441–452, I. Carey, M. Bruce, M. Horner, Y. Zen, L. D'Antiga, S. Bansal, D. Vergani and G. Mieli-Vergani

    Version of Record online : 3 OCT 2014, DOI: 10.1111/jvh.12316

  17. You have free access to this content
    Abstracts 890 to 1096


    Volume 46, Issue S1, October 2007, Pages: 632A–724A,

    Version of Record online : 19 SEP 2007, DOI: 10.1002/hep.22020

  18. You have free access to this content
    British HIV Association guidelines for the management of hepatitis viruses in adults infected with HIV 2013

    HIV Medicine

    Volume 14, Issue S4, November 2013, Pages: 1–71, Writing Group, Dr Ed Wilkins, Dr Mark Nelson, Dr Kosh Agarwal, Ms Dola Awoyemi, Dr Eleanor Barnes, Dr Sanjay Bhagani, Dr Gary Brook, Dr Ashley Brown, Ms Sheena Castelino, Dr Graham Cooke, Prof Martin Fisher, Prof Anna Maria Geretti, Mr Robert James, Dr Ranjababu Kulasegaram, Prof Clifford Leen, Prof David Mutimer, Dr Chloe Orkin, Dr Emma Page, Dr Adrian Palfreeman, Dr Padmasayee Papineni, Dr Alison Rodger and Dr CY William Tong

    Version of Record online : 25 OCT 2013, DOI: 10.1111/hiv.12106

  19. Quantitative HBV DNA levels as an early predictor of nonresponse in chronic HBe-antigen positive hepatitis B patients treated with interferon-alpha

    Journal of Viral Hepatitis

    Volume 13, Issue 2, February 2006, Pages: 96–103, A. A. Van Der Eijk, H. G. M. Niesters, B. E. Hansen, R. A. Heijtink, H. L. A. Janssen, S. W. Schalm and R. A. De Man

    Version of Record online : 19 SEP 2005, DOI: 10.1111/j.1365-2893.2005.00661.x

  20. Management of chronic hepatitis B virus infection: Current perspectives for the nurse practitioner

    Journal of the American Academy of Nurse Practitioners

    Volume 18, Issue 5, May 2006, Pages: 203–215, Robert Perrillo

    Version of Record online : 2 MAY 2006, DOI: 10.1111/j.1745-7599.2006.00124.x